---
audienceLevel: patient
cancerTypes:
- pancreatic
- kidney
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Mitomycin - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/mitomycin
version: v1
---

# Mitomycin - NCI

# Mitomycin

Placeholder slot

(MY-toh-MY-sin)

Mitomycin is an antibiotic used as a chemotherapy drug. It stops or slows the growth of cancer cells and other rapidly growing cells by damaging their DNA.

US Brand Name(s)

Jelmyto
Mitosol

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mitomycin&pagesize=20&page=1&audience=consumer)

## Use in Cancer

Mitomycin is approved
to be used alone or with other drugs to treat:

- **[Gastric](/Common/PopUps/popDefinition.aspx?id=46770&version=Patient&language=English) (stomach) and [pancreatic](/Common/PopUps/popDefinition.aspx?id=44074&version=Patient&language=English) [adenocarcinoma](/Common/PopUps/popDefinition.aspx?id=46216&version=Patient&language=English)** that is [locally advanced](/Common/PopUps/popDefinition.aspx?id=45955&version=Patient&language=English) or has [metastasized](/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=English) (spread to other parts of the body). It is used in patients whose disease has not gotten better with other types of treatment.
- **[Urothelial cancer](/Common/PopUps/popDefinition.aspx?id=783188&version=Patient&language=English)** in the upper [urinary tract](/Common/PopUps/popDefinition.aspx?id=46095&version=Patient&language=English). It is given directly into the [ureter](/Common/PopUps/popDefinition.aspx?id=46638&version=Patient&language=English) or [kidney](/Common/PopUps/popDefinition.aspx?id=46325&version=Patient&language=English) as a treatment for adults with [low-grade](/Common/PopUps/popDefinition.aspx?id=386213&version=Patient&language=English) disease. This use is approved for the Jelmyto brand of mitomycin.

Mitomycin
is also being studied in the treatment of other types of
cancer.

## More About Mitomycin

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/42674) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Mitomycin](https://medlineplus.gov/druginfo/meds/a682415.html) and [Mitomycin Pyelocalyceal](https://medlineplus.gov/druginfo/meds/a620027.html) - Lay language summaries of important information about these drugs. MedlinePlus information may include the following:

- warnings about the drug,
- what the drug is used for and how it is used,
- what you should tell your doctor before using the drug,
- what you should know about the drug before using it,
- other drugs that may interact with the drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Clinical Trials Accepting Patients

[Find Clinical Trials for Mitomycin](https://www.cancer.gov/research/participate/clinical-trials/intervention/C1820) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
